Response to the letter to the editor regarding our article 'statistical methodology for highly variable compounds: A novel design approach for the ofatumumab phase 2 bioequivalence study' https://doi.org/10.1002/pst.2233

Pharm Stat. 2022 Nov;21(6):1368-1369. doi: 10.1002/pst.2254. Epub 2022 Jul 20.

Byron Jones^{1

2}, Bingbing Li^{1

2}, Morten Bagger^{1

2}, Alex Goodyear^{1

2}, Inga Ludwig^{1

2}

No abstract available

Publication types